Antroquinonol administration in animal preclinical studies for Alzheimer's disease (AD): A new avenue for modifying progression of AD pathophysiology

Abe, 2000, Reactive oxygen species activate p90 ribosomal S6 kinase via Fyn and Ras, J. Biol. Chem., 275, 1739, 10.1074/jbc.275.3.1739 Aluise, 2010, Preclinical Alzheimer disease: brain oxidative stress, Abeta peptide and proteomics, Neurobiol. Dis., 39, 221, 10.1016/j.nbd.2010.04.011 Anand, 2017, The present and future of pharmacotherapy of Alzheimer's disease: a comprehensive review, Eur. J. Pharmacol., 815, 364, 10.1016/j.ejphar.2017.09.043 Andrews, 2018, Perinatal administration of phencyclidine alters expression of Lingo-1 signaling pathway proteins in the prefrontal cortex of juvenile and adult rats, Neuronal. Signal, 2, 10.1042/NS20180059 Angamuthu, 2019, Pharmacological activities of antroquinonol- Mini review, Chem. Biol. Interact., 297, 8, 10.1016/j.cbi.2018.10.009 Bahn, 2019, NRF2/ARE pathway negatively regulates BACE1 expression and ameliorates cognitive deficits in mouse Alzheimer's models, Proc. Natl. Acad. Sci. U. S. A., 116, 12516, 10.1073/pnas.1819541116 Bandookwala, 2020, 3-Nitrotyrosine: a versatile oxidative stress biomarker for major neurodegenerative diseases, Int. J. Neurosci., 130, 1047, 10.1080/00207454.2020.1713776 Block, 2007, Microglia-mediated neurotoxicity: uncovering the molecular mechanisms, Nat. Rev. Neurosci., 8, 57, 10.1038/nrn2038 Breijyeh, 2020, Comprehensive review on alzheimer's disease: causes and treatment, Molecules, 25, 10.3390/molecules25245789 Cacabelos, 2021, What is the gold standard model for Alzheimer's disease drug discovery and development?, Expet Opin. Drug Discov., 16, 1415, 10.1080/17460441.2021.1960502 Cassidy, 2020, Oxidative stress in alzheimer's disease: a review on emergent natural polyphenolic therapeutics, Compl. Ther. Med., 49, 10.1016/j.ctim.2019.102294 Chang, 2015, Antroquinonol lowers brain amyloid-beta levels and improves spatial learning and memory in a transgenic mouse model of alzheimer's disease, Sci. Rep., 5, 10.1038/srep15067 Cores, 2020, NRF2 regulation processes as a source of potential drug targets against neurodegenerative diseases, Biomolecules, 10, 10.3390/biom10060904 Cummings, 2019, Treatment combinations for alzheimer's disease: current and future pharmacotherapy options, J. Alzheimers Dis., 67, 779, 10.3233/JAD-180766 Davis, 1999, Alzheimer neuropathologic alterations in aged cognitively normal subjects, J. Neuropathol. Exp. Neurol., 58, 376, 10.1097/00005072-199904000-00008 Dickson, 1997, The pathogenesis of senile plaques, J. Neuropathol. Exp. Neurol., 56, 321, 10.1097/00005072-199704000-00001 Durand, 2000, Strain-dependent neurochemical and neuroendocrine effects of desipramine, but not fluoxetine or imipramine, in spontaneously hypertensive and Wistar-Kyoto rats, Neuropharmacology, 39, 2464, 10.1016/S0028-3908(00)00088-5 Fernandez, 2012, Wip1 phosphatase positively modulates dendritic spine morphology and memory processes through the p38MAPK signaling pathway, Cell Adhes. Migrat., 6, 333, 10.4161/cam.20892 Fragoulis, 2017, Oral administration of methysticin improves cognitive deficits in a mouse model of Alzheimer's disease, Redox Biol., 12, 843, 10.1016/j.redox.2017.04.024 Frick, 2018, Estradiol and hippocampal memory in female and male rodents, Curr. Opin. Behav. Sci., 23, 65, 10.1016/j.cobeha.2018.03.011 Hirata-Fukae, 2008, Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model, Brain Res., 1216, 92, 10.1016/j.brainres.2008.03.079 in: th (Ed.), Guide for the Care and Use of Laboratory Animals, Washington (DC), 2011. Iqbal, 1998, Mechanisms of neurofibrillary degeneration and the formation of neurofibrillary tangles, J. Neural. Transm. Suppl., 53, 169, 10.1007/978-3-7091-6467-9_15 Jafari, 2013, In vivo pharmacological evaluations of novel olanzapine analogues in rats: a potential new avenue for the treatment of schizophrenia, PLoS One, 8, 10.1371/journal.pone.0080979 Janelsins, 2005, Early correlation of microglial activation with enhanced tumor necrosis factor-alpha and monocyte chemoattractant protein-1 expression specifically within the entorhinal cortex of triple transgenic Alzheimer's disease mice, J. Neuroinflammation, 2, 23, 10.1186/1742-2094-2-23 Jones, 2001, Inflammation and Alzheimer's disease, Lancet, 358, 436, 10.1016/S0140-6736(01)05667-7 Kumar, 2011, Antroquinonol from ethanolic extract of mycelium of Antrodia cinnamomea protects hepatic cells from ethanol-induced oxidative stress through Nrf-2 activation, J. Ethnopharmacol., 136, 168, 10.1016/j.jep.2011.04.030 Larson, 2012, The complex PrP(c)-Fyn couples human oligomeric Abeta with pathological tau changes in Alzheimer's disease, J. Neurosci., 32, 10.1523/JNEUROSCI.1858-12.2012 Latta, 2015, Determining the role of IL-4 induced neuroinflammation in microglial activity and amyloid-beta using BV2 microglial cells and APP/PS1 transgenic mice, J. Neuroinflammation, 12, 41, 10.1186/s12974-015-0243-6 Lee, 2007, A new cytotoxic agent from solid-state fermented mycelium of Antrodia camphorata, Planta Med., 73, 1412, 10.1055/s-2007-990232 Lu, 2013, Recent research and development of Antrodia cinnamomea, Pharmacol. Ther., 139, 124, 10.1016/j.pharmthera.2013.04.001 Mancuso, 2012, Natural substances and Alzheimer's disease: from preclinical studies to evidence based medicine, Biochim. Biophys. Acta, 1822, 616, 10.1016/j.bbadis.2011.09.004 Morimoto, 2008, Estrogen replacement suppresses pressor response and oxidative stress induced by cage-switch stress in ovariectomized rats, Ann. N. Y. Acad. Sci., 1148, 213, 10.1196/annals.1410.045 Nygaard, 2018, Targeting Fyn kinase in alzheimer's disease, Biol. Psychiatr., 83, 369, 10.1016/j.biopsych.2017.06.004 Osama, 2020, Nrf2: a dark horse in Alzheimer's disease treatment, Ageing Res. Rev., 64, 10.1016/j.arr.2020.101206 Patel, 2005, Inflammatory cytokine levels correlate with amyloid load in transgenic mouse models of Alzheimer's disease, J. Neuroinflammation, 2, 9, 10.1186/1742-2094-2-9 Pini, 2016, Brain atrophy in Alzheimer's Disease and aging, Ageing Res. Rev., 30, 25, 10.1016/j.arr.2016.01.002 Preston, 2013, Interplay of hippocampus and prefrontal cortex in memory, Curr. Biol., 23, R764, 10.1016/j.cub.2013.05.041 Ramsey, 2007, Expression of Nrf2 in neurodegenerative diseases, J. Neuropathol. Exp. Neurol., 66, 75, 10.1097/nen.0b013e31802d6da9 Scearce-Levie, 2020, Leveraging preclinical models for the development of Alzheimer disease therapeutics, Nat. Rev. Drug Discov., 19, 447, 10.1038/s41573-020-0065-9 Schwab, 2010, Inflammation in transgenic mouse models of neurodegenerative disorders, Biochim. Biophys. Acta, 1802, 889, 10.1016/j.bbadis.2009.10.013 Senthil Kumar, 2020, A mechanistic and empirical review of antcins, a new class of phytosterols of formosan fungi origin, J. Food Drug Anal., 28, 38, 10.1016/j.jfda.2019.09.001 Serini, 2016, Reduction of oxidative/nitrosative stress in brain and its involvement in the neuroprotective effect of n-3 PUFA in alzheimer's disease, Curr. Alzheimer Res., 13, 123, 10.2174/1567205012666150921101147 Sevigny, 2016, The antibody aducanumab reduces Aβ plaques in Alzheimer's disease, Nature, 537, 50, 10.1038/nature19323 Song, 2017, Pharmacological modulation of functional phenotypes of microglia in neurodegenerative diseases, Front. Aging Neurosci., 9, 139, 10.3389/fnagi.2017.00139 Spires-Jones, 2014, The intersection of amyloid beta and tau at synapses in Alzheimer's disease, Neuron, 82, 756, 10.1016/j.neuron.2014.05.004 Steinhilb, 2007, Tau phosphorylation sites work in concert to promote neurotoxicity in vivo, Mol. Biol. Cell, 18, 5060, 10.1091/mbc.e07-04-0327 Streit, 2004, Microglia and neuroinflammation: a pathological perspective, J. Neuroinflammation, 1, 14, 10.1186/1742-2094-1-14 Sun, 2013, Traditional Chinese medicine: a promising candidate for the treatment of Alzheimer's disease, Transl. Neurodegener., 2, 6, 10.1186/2047-9158-2-6 Tam, 2019, Drugs for targeted therapies of alzheimer's disease, Curr. Med. Chem., 26, 335, 10.2174/0929867325666180430150940 Thiyagarajan, 2015, Antroquinonol targets FAK-signaling pathway suppressed cell migration, invasion, and tumor growth of C6 glioma, PLoS One, 10, 10.1371/journal.pone.0141285 Trepanier, 2012, Regulation of NMDA receptors by the tyrosine kinase Fyn, FEBS J., 279, 12, 10.1111/j.1742-4658.2011.08391.x Tuscher, 2015, Regulation of object recognition and object placement by ovarian sex steroid hormones, Behav. Brain Res., 285, 140, 10.1016/j.bbr.2014.08.001 Um, 2012, Alzheimer amyloid-beta oligomer bound to postsynaptic prion protein activates Fyn to impair neurons, Nat. Neurosci., 15, 1227, 10.1038/nn.3178 van Bokhoven, 2021, The Alzheimer's disease drug development landscape, Alzheimer's Res. Ther., 13, 186, 10.1186/s13195-021-00927-z Villa, 2015, Estrogen accelerates the resolution of inflammation in macrophagic cells, Sci. Rep., 5, 10.1038/srep15224 Villa, 2015, Estrogen accelerates the resolution of inflammation in macrophagic cells, Sci. Rep., 5, 10.1038/srep15224 Villaume, 2016, Scalable synthesis and preclinical biology of a phase 2 drug candidate, ACS Cent. Sci., 2, 27, 10.1021/acscentsci.5b00345 Vorhees, 2006, Morris water maze: procedures for assessing spatial and related forms of learning and memory, Nat. Protoc., 1, 848, 10.1038/nprot.2006.116 Wang, 2010, Allopregnanolone reverses neurogenic and cognitive deficits in mouse model of Alzheimer's disease, Proc. Natl. Acad. Sci. U. S. A., 107, 6498, 10.1073/pnas.1001422107 Wang, 2020, Upregulation of AMPK ameliorates alzheimer's disease-like tau pathology and memory impairment, Mol. Neurobiol., 57, 3349, 10.1007/s12035-020-01955-w Weekman, 2014, Transition from an M1 to a mixed neuroinflammatory phenotype increases amyloid deposition in APP/PS1 transgenic mice, J. Neuroinflammation, 11, 127, 10.1186/1742-2094-11-127 Wei, 2016, Potential therapeutic action of natural products from traditional Chinese medicine on Alzheimer's disease animal models targeting neurotrophic factors, Fundam. Clin. Pharmacol., 30, 490, 10.1111/fcp.12222 Xu, 2006, Estrogen, beta-amyloid metabolism/trafficking, and Alzheimer's disease, Ann. N. Y. Acad. Sci., 1089, 324, 10.1196/annals.1386.036 Yiannopoulou, 2020, Current and future treatments in alzheimer disease: an update, J. Cent. Nerv. Syst. Dis., 12